Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

The Effect of Customized Alerts Versus Generic Alerts for the Prescription of Warfarin and NSAID

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00880932

Enrollment

1865

Registered

2009-04-14

Start date

2006-08-31

Completion date

2007-12-31

Last updated

2009-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Warfarin and NSAID

Keywords

warfarin, NSAID, The condition is the concomitant prescription of

Brief summary

The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific reason for override on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.

Interventions

BEHAVIORALElectronic Alert

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

SINGLE (Caregiver)

Eligibility

Sex/Gender

ALL

Inclusion criteria

* All resident physicians (RP) and nurse practitioners (NP) involved in inpatient care at two hospitals of the University of Pennsylvania

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Decreased rate of prescription of the combination of warfarin and NSAID	17 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026